Scroll for more




Andrew Smith
Chief Financial Officer


Mr. Smith became our Chief Financial Officer in February 2015 after joining Sucampo in February 2011, first as Principal Accounting Officer and then as Vice President of Operations and Finance starting in January 2012. In addition to his direct role at the company, he was a financial consultant to Sucampo from June 2009 to February 2011.

Prior to  joining Sucampo, Mr. Smith was the Finance Director and Company Secretary for Retroscreen Virology Ltd., a contract virology company carrying out clinical and preclinical studies for pharmaceutical companies developing influenza vaccines, from 2006 to 2009. He also served as the Finance Director and Company Secretary of Clearlab Europe, a division of 1-800 Contacts Inc., following its acquisition of VisionTec CL, developer of the world’s first daily disposable contact lens, of which he was co-founder and member of its Board of Directors. In addition, he previously held senior financial management positions at Biocompatibles plc, Hydron Ltd (acquired by Biocompatibles) and Allergan Inc.

Mr. Smith is a member of the Board of Directors of the Tech Council of Maryland (TCM).

Mr. Smith is a Fellow of the Chartered Institute of Management Accountants and a Chartered Global Management Accountant.

Mr. Smith studied business and accounting at Liverpool John Moores University and Durham University Business School.

Contact Us
Tel: +1-301-961-3400